Glycosphingolipid levels were lower and cholesterol levels were higher in CD4+ T-cells from RRMS patients compared with HCs (Fig. 3A and B) which was not related to the proportion of CD4+ T-cells or distribution of T-cell subsets (Fig. 3C and F). This evidence concerns the gene CD4 and relapsing-remitting multiple sclerosis.